1. De Giorgi V, Saggini A, Grazzini M, et al. Specific challenges in the management of subungual melanoma. Expert Rev Anticancer Ther. 2011;11(5):749-61.
2. Nevares-Pomales OW, Sarriera-Lazaro CJ, Barrera-Llaurador J, et al. Pigmented lesions of the nail unit. Am J Dermatopathol. 2018;40:793-804.
4. Banfield CC, Redburn JC, Dawber RP. The incidence and prognosis of nail apparatus melanoma: a retrospective study of 105 patients in four English regions. Br J Dermatol. 1998;139:276-9.
9. Tan KB, Moncrieff M, Thompson JF, et al. Subungual melanoma: a study of 124 cases highlighting features of early lesions, potential pitfalls in diagnosis, and guidelines for histologic reporting. Am J Surg Pathol. 2007;31:1902-12.
10. Reilly DJ, Aksakal G, Gilmour RF, et al. Subungual melanoma: management in the modern era. J Plast Reconstr Aesthet Surg. 2017;70:1746-52.
11. Ishihara Y, Matsumoto K, Kawachi S, Saida T. Detection of early lesions of “ungual” malignant melanoma. Int J Dermatol. 1993;32:44-7.
13. Braun RP, Baran R, Le Gal FA, et al. Diagnosis and management of nail pigmentations. J Am Acad Dermatol. 2007;56:835-47.
14. Gregorcyk S, Shelton RM, Ladaga LE, Perry RR. Pathologic fracture secondary to subungual melanoma. J Surg Oncol. 1996;61:230-3.
15. Nguyen JT, Bakri K, Nguyen EC, Johnson CH, Moran SL. Surgical management of subungual melanoma: mayo clinic experience of 124 cases. Ann Plast Surg. 2013;71:346-54.
16. Moehrle M, Metzger S, Schippert W, Garbe C, Rassner G, Breuninger H. “Functional” surgery in subungual melanoma. Dermatol Surg. 2003;29:366-74.
19. Duarte AF, Correia O, Barros AM, Ventura F, Haneke E. Nail melanoma in situ: clinical, dermoscopic, pathologic clues, and steps for minimally invasive treatment. Dermatol Surg. 2015;41:59-68.
21. Ronger S, Touzet S, Ligeron C, et al. Dermoscopic examination of nail pigmentation. Arch Dermatol. 2002;138:1327-33.
22. Mun JH, Kim GW, Jwa SW, et al. Dermoscopy of subungual haemorrhage: its usefulness in differential diagnosis from nail-unit melanoma. Br J Dermatol. 2013;168:1224-9.
23. Saida T, Ohshima Y. Clinical and histopathologic characteristics of early lesions of subungual malignant melanoma. Cancer. 1989;63:556-60.
24. Yun SJ, Kim SJ. Images in clinical medicine: Hutchinson’s nail sign. N Engl J Med. 2011;364:e38.
26. Cooper C, Arva NC, Lee C, et al. A clinical, histopathologic, and outcome study of melanonychia striata in childhood. J Am Acad Dermatol. 2015;72:773-9.
28. Lee WJ, Lee JH, Won CH, et al. Nail apparatus melanoma: a comparative, clinicoprognostic study of the initial clinical and morphological characteristics of 49 patients. J Am Acad Dermatol. 2015;73:213-20.
29. Levit EK, Kagen MH, Scher RK, Grossman M, Altman E. The ABC rule for clinical detection of subungual melanoma. J Am Acad Dermatol. 2000;42(2 Pt 1):269-74.
30. Ko D, Oromendia C, Scher R, Lipner SR. Retrospective single-center study evaluating clinical and dermoscopic features of longitudinal melanonychia, ABCDEF criteria, and risk of malignancy. J Am Acad Dermatol. 2019;80:1272-83.
34. Light RJ. Measures of response agreement for qualitative data: some generalizations and alternatives. Psychol Bull. 1971;76:365-77.
35. Di Chiacchio N, Hirata SH, Enokihara MY, Michalany NS, Fabbrocini G, Tosti A. Dermatologists’ accuracy in early diagnosis of melanoma of the nail matrix. Arch Dermatol. 2010;146:382-7.
36. Hirata SH, Yamada S, Enokihara MY, et al. Patterns of nail matrix and bed of longitudinal melanonychia by intraoperative dermatoscopy. J Am Acad Dermatol. 2011;65:297-303.
38. Ohn J, Choe YS, Mun JH. Dermoscopic features of nail matrix nevus (NMN) in adults and children: a comparative analysis. J Am Acad Dermatol. 2016;75:535-40.
42. Haneke E, Baran R. Longitudinal melanonychia. Dermatol Surg. 2001;27:580-4.
43. de Berker DA. Lateral longitudinal nail biopsy. Australas J Dermatol. 2001;42:142-4.
44. Richert B, Theunis A, Norrenberg S, André J. Tangential excision of pigmented nail matrix lesions responsible for longitudinal melanonychia: evaluation of the technique on a series of 30 patients. J Am Acad Dermatol. 2013;69:96-104.
45. Zhou Y, Chen W, Liu ZR, Liu J, Huang FR, Wang DG. Modified shave surgery combined with nail window technique for the treatment of longitudinal melanonychia: evaluation of the method on a series of 67 cases. J Am Acad Dermatol. 2019;81:717-22.
46. Park SW, Jang KT, Lee JH, et al. Scattered atypical melanocytes with hyperchromatic nuclei in the nail matrix: diagnostic clue for early subungual melanoma in situ. J Cutan Pathol. 2016;43:41-52.
47. Amin B, Nehal KS, Jungbluth AA, et al. Histologic distinction between subungual lentigo and melanoma. Am J Surg Pathol. 2008;32:835-43.
48. Husain S, Scher RK, Silvers DN, Ackerman AB. Melanotic macule of nail unit and its clinicopathologic spectrum. J Am Acad Dermatol. 2006;54:664-7.
50. Darmawan CC, Jo G, Montenegro SE, et al. Early detection of acral melanoma: a review of clinical, dermoscopic, histopathologic, and molecular characteristics. J Am Acad Dermatol. 2019;81:805-12.
56. Chow WT, Bhat W, Magdub S, Orlando A. In situ subungual melanoma: digit salvaging clearance. J Plast Reconstr Aesthet Surg. 2013;66:274-6.
57. Cochran AM, Buchanan PJ, Bueno RA Jr, Neumeister MW. Subungual melanoma: a review of current treatment. Plast Reconstr Surg. 2014;134:259-73.
58. Jo G, Cho SI, Choi S, Mun JH. Functional surgery versus amputation for in situ or minimally invasive nail melanoma: a meta-analysis. J Am Acad Dermatol. 2019;81:917-22.
59. Flores-Terry M, Romero-Aguilera G, Mendoza C, et al. Functional surgery for malignant subungual tumors: a case series and literature review. Actas Dermosifiliogr (Engl Ed). 2018;109:712-21.
62. Kim BJ, Kim J, Hu J, Kwak Y, Kwon ST. Functional surgery for subungual melanoma: surgical tips based on histological analysis of 21 cadavers. Dermatol Surg. 2022;48:7-11.
63. Yoo H, Kim H, Kwon ST, et al. Tumor invasion in the hyponychium is associated with distant metastasis and poor prognosis in subungual melanoma: a histologic landscape of 44 cases. J Am Acad Dermatol. 2022;86:1027-34.
64. Brodland DG. The treatment of nail apparatus melanoma with Mohs micrographic surgery. Dermatol Surg. 2001;27:269-73.
65. Matsumoto A, Strickland N, Nijhawan RI, Srivastava D. Nail unit melanoma in situ treated with mohs micrographic surgery. Dermatol Surg. 2021;47:98-103.
66. Finley RK 3rd, Driscoll DL, Blumenson LE, Karakousis CP. Subungual melanoma: an eighteen-year review. Surgery. 1994;116:96-100.
67. Lee KT, Park BY, Kim EJ, et al. Superthin SCIP flap for reconstruction of subungual melanoma: aesthetic functional surgery. Plast Reconstr Surg. 2017;140:1278-89.
68. Park JU, Kim K, Kwon ST. Venous free flaps for the treatment of skin cancers of the digits. Ann Plast Surg. 2015;74:536-42.
70. Woo SJ, Ma IZ, Kwon ST, Park SO, Kim BJ, Hong KY. Long-term results of wide local excision with concurrent venous free flap reconstruction in subungual melanoma. Arch Hand Microsurg. 2022;27:240-6.
72. Martin DE, English JC, Goitz RJ. Subungual malignant melanoma. J Hand Surg Am. 2011;36:704-7.
73. Hinchcliff KM, Pereira C. Subungual tumors: an algorithmic approach. J Hand Surg Am. 2019;44:588-98.
75. Sinno S, Wilson S, Billig J, Shapiro R, Choi M. Primary melanoma of the hand: an algorithmic approach to surgical management. J Plast Surg Hand Surg. 2015;49:339-45.
78. Swetter SM, Tsao H, Bichakjian CK, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2019;80:208-50.
79. Curti BD, Faries MB. Recent advances in the treatment of melanoma. N Engl J Med. 2021;384:2229-40.
80. Pavri SN, Clune J, Ariyan S, Narayan D. Malignant melanoma: beyond the basics. Plast Reconstr Surg. 2016;138:330e-340e.
84. Nakamura Y, Namikawa K, Yoshino K, et al. Anti-PD1 checkpoint inhibitor therapy in acral melanoma: a multicenter study of 193 Japanese patients. Ann Oncol. 2020;31:1198-206.